[HTML][HTML] Progress towards elimination goals for viral hepatitis
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and
hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top …
hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top …
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Background It is unclear whether tenofovir disoproxil fumarate and entecavir differ in their
association with risk of hepatocellular carcinoma in patients with chronic hepatitis B, and …
association with risk of hepatocellular carcinoma in patients with chronic hepatitis B, and …
Tenofovir versus entecavir on recurrence of hepatitis B virus–related hepatocellular carcinoma after surgical resection
Background and Aims Studies have suggested that tenofovir disoproxil fumarate (TDF)
treatment is associated with a significantly lower risk of hepatocellular carcinoma (HCC) …
treatment is associated with a significantly lower risk of hepatocellular carcinoma (HCC) …
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …
Effects of tenofovir vs entecavir on risk of hepatocellular carcinoma in patients with chronic HBV infection: a systematic review and meta-analysis
Background & Aims Tenofovir disoproxil fumarate (TDF) and entecavir are recommended as
first-line treatments for chronic hepatitis B virus (HBV) infection. However, there is debate …
first-line treatments for chronic hepatitis B virus (HBV) infection. However, there is debate …
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
Background & Aims A recent study in Asian patients with chronic hepatitis B (CHB) reported
that the incidence of hepatocellular carcinoma (HCC) was lower in patients treated with …
that the incidence of hepatocellular carcinoma (HCC) was lower in patients treated with …
[HTML][HTML] Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
HJ Yim, JH Kim, JY Park, EL Yoon, H Park… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Clinical practice guidelines are important for guiding the management of specific diseases
by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as …
by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as …
Risk of hepatocellular carcinoma with tenofovir vs entecavir treatment for chronic hepatitis B virus: a reconstructed individual patient data meta-analysis
Importance Conventional meta-analyses with aggregated study-level data have yielded
conflicting results for the comparative effectiveness of tenofovir disoproxil fumarate vs …
conflicting results for the comparative effectiveness of tenofovir disoproxil fumarate vs …
[HTML][HTML] Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis
Background & Aims The comparative risk of hepatocellular carcinoma (HCC) in patients with
chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) vs. entecavir (ETV) …
chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) vs. entecavir (ETV) …
Comparative effectiveness of entecavir versus tenofovir for preventing hepatocellular carcinoma in patients with chronic hepatitis B: a systematic review and meta …
Background and Aims Chronic hepatitis B (CHB) can lead to hepatocellular carcinoma
(HCC). While both tenofovir disoproxil (TDF) and entecavir (ETV) have been shown to …
(HCC). While both tenofovir disoproxil (TDF) and entecavir (ETV) have been shown to …